Tokyo Tape
Sign in
← Perseus Proteomics

Quarterly report · Q2

4882.TEDINET S100S7IX
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥51m2023-04-01 → 2023-09-30StandaloneNet sales
Revenue¥94m2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥48m2022-04-01 → 2022-09-30StandaloneNet sales
Operating income−¥444m2023-04-01 → 2023-09-30StandaloneOperating income
Operating income−¥307m2022-04-01 → 2022-09-30StandaloneOperating income
Ordinary income−¥429m2023-04-01 → 2023-09-30StandaloneOrdinary income
Ordinary income−¥690m2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥289m2022-04-01 → 2022-09-30StandaloneOrdinary income
Profit before tax−¥633m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax−¥362m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Net income−¥633m2023-04-01 → 2023-09-30StandaloneProfit loss
Net income−¥787m2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income−¥363m2022-04-01 → 2022-09-30StandaloneProfit loss
Total assets¥2.0bnat 2023-09-30StandaloneAssets
Total assets¥2.6bnat 2023-03-31StandaloneAssets
Total assets¥2.9bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥206mat 2023-09-30StandaloneLiabilities
Total liabilities¥170mat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.8bnat 2023-09-30StandaloneNet assets
Net assets / equity¥2.4bnat 2023-03-31StandaloneNet assets
Net assets / equity¥2.8bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.9bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥2.4bnat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥1.9bnat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥2.4bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥2.8bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2022-03-31dStandaloneCash and cash equivalents
Operating cash flow−¥465m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥564m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥256m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥129m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥213m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥156m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow−¥20,0002022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥20,0002022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-53.872023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-17.972023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.932022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-30.872022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-13.842022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio87.0%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio92.2%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio96.5%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued11,759,400at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued11,759,400at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued11,759,400at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 370
ItemContextValueUnit
Capital surplusCurrentQuarterInstant_NonConsolidatedMember2225142000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-1799240000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember-2432727000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-20000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-20000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember2365134000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember1731647000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember31411000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember52295000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember2396545000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember1783942000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember2566650000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember1989786000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember47500000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember50937000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember2834000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember5221000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember44665000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember45716000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember214034000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember303635000JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember137320000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember186334000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember351354000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember489969000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-306688000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-444252000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember26000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember24000JPY
Subsidy income noi bountyPrior1YTDDuration_NonConsolidatedMember285000JPY
Subsidy income noi bountyCurrentYTDDuration_NonConsolidatedMember－JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember17791000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember15154000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember1000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember0JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember18103000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember15180000JPY
Other noePrior1YTDDuration_NonConsolidatedMember19000JPY
Other noeCurrentYTDDuration_NonConsolidatedMember11000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember19000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember11000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-288604000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-429084000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration_NonConsolidatedMember－JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration_NonConsolidatedMember47000JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember－JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember47000JPY
Impairment loss elPrior1YTDDuration_NonConsolidatedMember73481000JPY
Impairment loss elCurrentYTDDuration_NonConsolidatedMember134208000JPY
Head office transfer cost elPrior1YTDDuration_NonConsolidatedMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass